Riskpilot← Back to searchSign inGet full accessApofysio ApS
APSActiveCVR 38648519Gladsaxevej 384CPhysiotherapy activities · NACE 8695Est. 20179 employeeswww.apofysio.dk
Revenue 2024
DKK 4,5M
0% vs 2023
EBITDA margin
4.5%
-40% vs 2023
Equity ratio
1.7%
Financial strength
Net profit 2024
DKK 164K
-30% vs 2023
| Revenue | DKK 4,5M | +0% |
| EBITDA | DKK 201K | -40% |
| Net profit | DKK 164K | -30% |
| Total assets | DKK 1,8M | +48% |
| Equity | DKK 30K | +104% |
| Employees | 9 | — |
Legal name
Apofysio ApS
CVR number
38648519
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
4. maj 2017
Share capital
DKK 50.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er fysioterapeutvirksomhed og virksomhed, der er naturligt forbundet hermed.
Address
Gladsaxevej 384C
Phone
+4560209593
Email
info@apofysio.dk
Website
www.apofysio.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.447 | 2.737 | 3.526 | 2.077 | 4.064 | 3.970 | 4.500 | 4.488 |
| Staff expenses | -803 | -2.388 | -3.709 | -3.262 | -3.377 | -3.214 | -3.581 | -3.763 |
| EBITDA | 152 | 350 | -183 | -1.690 | 163 | 223 | 335 | 201 |
| Depreciation & amort. | -41 | -71 | -77 | -62 | -24 | -18 | -13 | -0 |
| EBIT | 110 | 278 | -259 | -1.752 | 139 | 205 | 322 | 201 |
| Net financials | -3 | -6 | -9 | -16 | -15 | -9 | -14 | -0 |
| Profit before tax | 108 | 272 | -268 | -1.768 | 125 | 196 | 307 | 201 |
| Tax | 24 | 60 | -57 | -388 | 25 | 45 | 73 | 37 |
| Net profit | 83 | 212 | -211 | -1.380 | 100 | 151 | 234 | 164 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 453 | 902 | 952 | 1.059 | 1.365 | 1.389 | 1.241 | 1.835 |
| Equity | 133 | 345 | -66 | -1.446 | -1.345 | -1.194 | -746 | 30 |
| Long-term debt | 0 | 0 | 308 | 186 | 194 | 287 | 94 | 94 |
| Short-term debt | 315 | 556 | 709 | 2.319 | 2.516 | 2.296 | 1.893 | 1.538 |
| Total debt | 315 | 556 | 1.018 | 2.504 | 2.710 | 2.583 | 1.987 | 1.632 |
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
20172024
Equity ratio
1.7%
This company
38.2%
Market median
-96% vs market
20172024
Return on equity
537.8%
This company
18.4%
Market median
+2823% vs market
20172024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20172024
Asset turnover
2.44×
This company
1.12×
Market median
+118% vs market
20172024
Debt / equity
59.36×
This company
0.62×
Market median
-9474% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-05-04 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SH Management | Management | 2017 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hein Sommer Holding ApS | Company | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hein Sommer Holding ApS
Apofysio ApS Board members of Apofysio ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Hein Sommer | Management | 0 companies |